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The mitochondrial DNA (mtDNA) of 87 index cases with Leber hereditary optic neuropathy (LHON) sequentially
diagnosed in Italy, including an extremely large Brazilian family of Italian maternal ancestry, was evaluated in
detail. Only seven pairs and three triplets of identical haplotypes were observed, attesting that the large majority
of the LHON mutations were due to independent mutational events. Assignment of the mutational events into
haplogroups conﬁrmed that J1 and J2 play a role in LHON expression but narrowed the association to the subclades
J1c and J2b, thus suggesting that two speciﬁc combinations of amino acid changes in the cytochrome b are the
cause of the mtDNA background effect and that this may occur at the level of the supercomplex formed by
respiratory-chain complexes I and III. The families with identical haplotypes were genealogically reinvestigated,
which led to the reconnection into extended pedigrees of three pairs of families, including the Brazilian family with
its Italian counterpart. The sequencing of entire mtDNA samples from the reconnected families conﬁrmed the
genealogical reconstruction but showed that the Brazilian family was heteroplasmic at two control-region positions.
The survey of the two sites in 12 of the Brazilian subjects revealed triplasmy in most cases, but there was no
evidence of the tetraplasmy that would be expected in the case of mtDNA recombination.
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In the past decade, haplogroups of the mitochondrial ge-
nome were extensively and successfully used as tools for
investigating human origin and evolution (Macaulay et
al. 2005). However, mtDNA is not only a string of DNA
with peculiar features useful for evolutionary studies, but
it also contains genes involved in the generation of cel-
lular energy through the process of oxidative phospho-
rylation. Thus, the high mutation rate of the mitochon-
drial genome has resulted not only in the accumulation
of the broad spectrum of sequence polymorphisms that
distinguish haplogroups and subhaplogroups but also in
a large number of disease-causing mutations. These dis-
eases generally manifest in organs and tissues that rely
heavily on mitochondrial energy production (Wallace
2005).
Leber hereditary optic neuropathy (LHON [MIM
535000]) was the ﬁrst disease to be linked with an
mtDNA point mutation (Wallace et al. 1988) and is
characterized by a maternally inherited loss of central
vision, which occurs most frequently in males. Three
mtDNA point mutations affecting the ND (NADH de-
hydrogenase) subunits of the respiratory enzyme com-
plex I (11778/ND4, 3460/ND1, and 14484/ND6) are
commonly found worldwide and are well established as
pathogenic. However, other rare pathogenic mutations
continue to be reported in a minority of families negative
for the above-named common mutations, all involving
complex I (for reviews, see Carelli et al. [2004] andNew-
man [2005]).
In addition to the search for disease-causing muta-
tions, the sequence variation of the human mitochondrial
genome has been the focus of numerous studies inves-
tigating its role as a contributing factor in the pathogen-
esis of neurodegenerative diseases (Howell et al. 2005;
Wallace 2005). Indeed, it has been proposed that certain
mtDNA polymorphisms, or combinations thereof, may
confer a higher risk for certain complex diseases—in
other words, that the supposedly “neutral” mutations
that deﬁne haplogroups and subhaplogroups play a role
in disease expression (Torroni and Wallace 1994). The
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ﬁrst strong evidence of such a haplogroup effect was
reported in 1997, again the result of studying LHON.
Four concomitant investigations performed on patients
of diverse European origins revealed that the LHON
mutations 11778/ND4 and 14484/ND6 were preferen-
tially associated with the western Eurasian haplogroup
J (Brown et al. 1997; Hofmann et al. 1997; Lamminen
et al. 1997; Torroni et al. 1997). This observation led
to the idea that the mutational motif in ND subunits
that deﬁnes haplogroup J—4216C/ND1-10398G/ND3-
13708A/ND5—might increase the penetrance of the
11778/ND4 and 14484/ND6 mutations and the risk of
disease expression (Torroni et al. 1997).
After these ﬁndings about LHON, association studies
with haplogroups became a common approach to un-
ravel the role of mtDNA-sequence variation in various
disorders and phenotypes, and the number of studies
has grown exponentially. For example, haplogroup J has
also been associated with successful aging (De Benedictis
et al. 1999; Ross et al. 2001; Niemi et al. 2003), and
associations have been reported between haplogroup U
and occipital stroke in migraine (Majamaa et al. 1998),
haplogroup J and optic neuritis (Reynier et al. 1999),
haplogroup T and asthenozoospermia (Ruiz-Pesini et
al. 2000), haplogroup H and both migraine without
aura and cyclic vomiting syndrome (Wang et al. 2004),
haplogroup D4h and bipolar disorder (Munakata et al.
2004), and haplogroups J2 and K and sprint athletic
performances (Niemi andMajamaa 2005). However, ex-
cept for LHON, virtually all reported associations be-
tween haplogroups and diseases have remained provi-
sional. The ﬁndings of one study have rarely been rep-
licated by studies of other populations, and conﬂicting
associations have been often reported. One striking ex-
ample of inconsistency is highlighted by the recent stud-
ies of Parkinson disease (PD). It has been proposed that
a reduced risk of PD for Europeans is associated with
haplogroups J and K (van der Walt et al. 2003), the
supercluster UKJT (Pyle et al. 2005), or haplogroup K
alone (Ghezzi et al. 2005), whereas other studies sug-
gested an increased risk with either the superhaplogroup
JT (Ross et al. 2003) or the supercluster JTIWX (Autere
et al. 2004).
Association studies can be confounded if patients and
controls are not well matched. However, mtDNA asso-
ciation studies are probably also affected by another ma-
jor speciﬁc problem: the resolution of the mtDNA hap-
logroup structure is generally low. A recent study con-
ﬁrms that mtDNA association analyses performed so
far have been too simplistic (Achilli et al. 2004). It
showed that haplogroup H—by far the most common
haplogroup in Europe, with a uniformly high frequency
(30%–50%)—is divided into numerous subhaplogroups
whose frequency is very different in European regions.
Such differential frequency distributions alone could eas-
ily explain some of the inconsistent results obtained by
association studies performed on different European
populations.
In the past few years, some studies have raised doubts
even about what was considered the strongest of the
associations, that between LHON and haplogroup J. A
survey of Iranian patients with LHON did not detect such
an association (Houshmand et al. 2004), and a rather
large number of Dutch, French, and French-Canadian
LHON-affected families harboring the 14484/ND6 mu-
tation were found to share a haplotype characterized by
the rare motif 3394A-16213A (Macmillan et al. 2000;
Howell et al. 2003; Laberge et al. 2005). This observa-
tion revealed a founder event that might have occurred
900–1,800 years ago (Howell et al. 2003). The discovery
of this founder event in western Europe, although con-
ﬁrming that haplotype analysis is a powerful tool to
reconnect apparently unrelated LHON-affected families
into extended pedigrees, raises the possibility that at least
part of the preferential association between haplogroup
J and the mutations 14484/ND6 and 11778/ND4 ob-
served in Europeansmight be explained by founder events
rather than by an effect of the mtDNA background.
Another controversial issue in human mitochondrial
genomics, with major implications for molecular and
evolutionary studies, is whether mtDNA undergoes re-
combination. Experimental evidence of mtDNA recom-
bination in humans was recently obtained for the only
subject reported with biparental inheritance of mtDNA
(Kraytsberg et al. 2004), in an in vitro cell-culture system
(D’Aurelio et al. 2004), and in the skeletal muscle of
individuals with multiple mtDNA heteroplasmy (Zsurka
et al. 2005). However, no studies have evaluated the
possibility of mtDNA recombination by studying human
pedigrees, which are probably the most informative bio-
logical context for investigation of this issue.
The present study, which was performed on mtDNAs
from 86 Italian index subjects with LHON and one Bra-
zilian family of maternal Italian ancestry, is aimed at
clarifying the impact of founder effects on the associa-
tion of the LHON mutations 11778/ND4 and 14484/
ND6 with haplogroup J, as opposed to the previously
hypothesized functional effect of the mtDNAbackground
(Man et al. 2004). We also investigated, by dissecting
haplogroup J into subclades, whether the associationwith
LHON mutations was restricted to subsets of J char-
acterized by differential ethnic/geographic distributions
and peculiar arrays of nonsynonymous polymorphisms
with the potential for a functional effect. Finally, we per-
formed a genealogical reconnection into extended ped-
igrees of some LHON-affected families harboring hap-
lotype identities. Two heteroplasmic nucleotide substitu-
tions that occurred in one extended pedigree were evalu-
ated to detect mtDNA recombination.
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Table 1
RFLP and Control-Region mtDNA Haplotypes from 1
Brazilian and 86 Italian Probands with LHON
The table is available in its entirety in the online
edition of The American Journal of Human Genetics.
Subjects and Methods
LHON Samples
The study was performed on the mtDNA of 86 Italian index
cases with LHON who harbored a known causative LHON
mutation (66 subjects with 11778/ND4, 13 subjects with 3460/
ND1, 6 subjects with 14484/ND6, and 1 subject with 14482A/
ND6) and who were sequentially identiﬁed in three Italian
diagnostic centers (Dipartimento di ScienzeNeurologiche, Uni-
versita` di Bologna, Bologna; Istituto Neurologico Nazionale
“Carlo Besta,” Milan; and Policlinico Universita` “La Sap-
ienza,” Rome). An additional Brazilian family of Italian ma-
ternal ancestry with the LHON 11778/ND4 mutation (SOA-
BR) (Sadun et al. 2003) was also included in the study. The
control group consisted of 2,071 unrelated Italians. Appro-
priate informed consent was obtained from all subjects.
Analysis of mtDNA-Sequence Variation
Genomic DNA was extracted from blood by standard pro-
cedures. High-resolution RFLP analysis of mtDNA was then
performed and was accompanied, as reported elsewhere (Tor-
roni et al. 2003), by sequencing 740–820 nt of the mtDNA
control region, beginning at nucleotide position (np) 16000.
This allowed the construction of high-resolution haplotypes
and the identiﬁcation of diagnostic haplogroup markers. For
haplogroup and subhaplogroup afﬁliation of both patient and
control mtDNA samples, the most-recent phylogenetic data on
western Eurasian haplogroups and subhaplogroups were taken
into account (Achilli et al. 2004, 2005; Palanichamy et al. 2004;
Kivisild et al. 2005), and, whenever necessary, both control
and LHON mtDNA samples were screened for additional di-
agnostic markers. Sequencing of entire mtDNA samples and
phylogeny construction were performed as described elsewhere
(Torroni et al. 2001; Achilli et al. 2004).
Quantiﬁcation of Heteroplasmy
The level of heteroplasmy at np 16092 and np 16129 in 17
mtDNA samples from the reconnected LB10 and BSL07 fam-
ilies was evaluated by using the forward primer 16060–16090
with the mismatch position 16088A, which introduces an ScaI
restriction site in the presence of 16092C, and the reverse
primer 16260–16280. The 16129A mutation introduces a
Bsp1407I restriction site, and it can be recognized on the same
amplicon as 16092C. The quantiﬁcation of heteroplasmy was
performed by densitometry on gel photographs by use of the
Fluor-S MAX Multimager System (Biorad).
Statistics
Statistical analyses were performed using the SSPS statistical
package, version 12.0, and statistical signiﬁcance was estab-
lished at . Binary logistic-regression analysis was usedap 0.05
to assess the association between haplogroups and LHON. Be-
cause haplogroup afﬁliation is a categorical independent var-
iable with more than two categories, we performed a logistic
regression of all haplogroup categories at one time (to look
for any effect), using haplogroup H* as a reference level. Be-
cause the categories U* and “others” were absent among sub-
jects with LHON, those categories were aggregated with L1b.
The distribution of LHON mutations on J1 and J2 and their
subclades was evaluated using the Fisher’s exact test.
Results
Haplotype Analysis of mtDNA from Probands
with LHON
High-resolution RFLP analysis and control-region se-
quencing revealed that, among the 67 mtDNA samples
with the 11778/ND4 mutation, there were 55 different
haplotypes (6 double- and 3 triple-haplotype identities,
including the Brazilian proband); among the 13 mtDNA
samples carrying the 3460/ND1 mutation, there were 12
different haplotypes (only 1 pair with an identical haplo-
type), and the 6mtDNA samples carrying the 14484/ND6
mutation fell into 6 different haplotypes (table 1). Note
that none of the Italian 14484/ND6 haplotypes harbored
the distinguishing 3394A-16213A motif associated with
the 14484/ND6 Dutch/French founder event described
above.
This haplotype distribution strongly suggests 74 inde-
pendent mutational events among the 87 LHON-af-
fected families: 55 occurrences of the 11778/ND4 mu-
tation, 12 occurrences of the 3460/ND1 mutation, 6 oc-
currences of the 14484/ND6mutation, and 1 occurrence
of the 14482A/ND6 mutation (Valentino et al. 2002).
Indeed, even those mtDNAs with the same LHON mu-
tation that were members of the same haplogroup/sub-
haplogroup—and thus could theoretically harbor the
LHON mutation by descent—generally differed by sev-
eral mutations in both the coding and the control regions
(table 1). Moreover, many of their different control-re-
gion motifs have been observed in a random sample of
2,071 mtDNA samples from the general Italian popu-
lation, which is further support of the independence of
the LHON mutational events. On the other hand, with
the same rationale, pairs and triplets of identical hap-
lotypes most likely represent pedigrees that are only
apparently unrelated but that, in reality, acquired the
LHON mutation by descent from a common female an-
cestor. However, we cannot completely exclude the pos-
sibility that the same LHON mutation might have oc-
curred twice on mtDNA samples with the same haplo-
types, even though the probability would, in general, be
very low.
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Table 2
Haplogroup Distribution of LHON Mutational Events in Italian Patients with LHON
Relative to Italian Control Individuals
HAPLOGROUP
NO. (%) OF LHON MUTATIONAL EVENTS
Patients
Control
Individuals
( )np 2,071
11778
( )np 55
3460
( )np 12
14484
( )np 6
14482A
( )np 1
Total
( )np 74
H*a 12 (21.8) 4 (33.3) … … 16 (21.6) 454 (21.9)
H1 2 (3.6) 1 (8.3) … … 3 (4.1) 216 (10.4)
H3 2 (3.6) … … … 2 (2.7) 57 (2.8)
H5 1 (1.8) … … … 1 (1.4) 109 (5.3)
V … 1 (8.3) … … 1 (1.4) 66 (3.2)
pre*V 2 (3.6) … … … 2 (2.7) 25 (1.2)
HV 3 (5.5) … … … 3 (4.1) 71 (3.4)
pre-HV 1 (1.8) … … … 1 (1.4) 15 (.7)
J1 9 (16.4) … 4 (66.7) 1 (100.0) 14 (18.9) 119 (5.7)
J2 4 (7.3) … … … 4 (5.4) 29 (1.4)
T1 2 (3.6) 1 (8.3) … … 4 (5.4) 50 (2.4)
T2 2 (3.6) … 1 (16.7) … 2 (2.7) 181 (8.7)
U*b … … … … … 34 (1.6)
U1 … 1 (8.3) … … 1 (1.4) 23 (1.1)
U2e 1 (1.8) … … … 1 (1.4) 18 (.9)
U3 … 1 (8.3) … … 1 (1.4) 54 (2.6)
U4 … 1 (8.3) … … 1 (1.4) 41 (2.0)
U5a 1 (1.8) … … … 1 (1.4) 72 (3.5)
U5b 2 (3.6) … … … 2 (2.7) 47 (2.3)
U6 2 (3.6) … … … 2 (2.7) 12 (.6)
K 5 (9.1) … … … 5 (6.8) 154 (7.4)
I 1 (1.8) … … … 1 (1.4) 40 (1.9)
N1b 1 (1.8) … … … 1 (1.4) 20 (1.0)
W 1 (1.8) 1 (8.3) … … 2 (2.7) 38 (1.8)
X … 1 (8.3) 1 (16.7) … 2 (2.7) 68 (3.3)
L1b 1 (1.8) … … … 1 (1.4) 2 (.1)
Others … … … … … 56 (2.7)
a H* includes H mtDNAs except those that belong to the subhaplogroups H1, H3, and
H5.
b U* includes mtDNAs that belong to the subhaplogroups U7, U8, and U9.
Distribution of LHON Mutational Events
into Haplogroups
The next step in the study was to evaluate the distri-
bution of the 74 plausible LHONmutational events into
haplogroups and subhaplogroups. This distribution is
illustrated in table 2. The frequency values were com-
pared with the haplogroup frequencies observed in a
sample of 2,071 unrelated Italian controls.
A binary logistic regression was performed on the data
shown in table 2, to ﬁrst assess the risk of mtDNA hap-
logroups with LHON (all mutations pooled). In the lo-
gistic regression, we evaluated the likelihood of the entire
model by the P value associated with the likelihood-ratio
test (the null hypothesis is that all slopes are equal to
zero) and found a signiﬁcant P value of .019, which
indicates that at least one predictor (haplogroup) is sig-
niﬁcantly associated with the response. Among the pre-
dictors, only haplogroups J1 and J2 were found to sig-
niﬁcantly affect the risk of LHON,with odds ratios (ORs)
indicating an increased risk (for J1, , 95%ORp 3.36
CI 1.60–7.08, ; for J2, , 95% CIPp .001 ORp 3.94
1.24–12.54, ). To conﬁrm that these haplo-Pp .020
groups were the only ones affecting LHON expression,
we repeated the logistic-regression model excluding hap-
logroups J1 and J2. In that case, the likelihood-ratio test
showed a P value of .558, which conﬁrms the absence
of signiﬁcant associations with other haplogroups.
We then evaluated whether either haplogroup J1 or
haplogroup J2 was differentially associated with the
three most-common primary LHON mutations by using
a two-tailed Fisher’s exact test (table 3). A signiﬁcant
association was observed between the 11778/ND4 mu-
tation and both haplogroups J1 and J2 and between the
14484/ND6 mutation and haplogroup J1. However, hap-
logroups J1 and J2 are made up of well-deﬁned sub-
clades: J1b, J1c, and J1d for J1 (the last is newly deﬁned
in this study; see below) and J2a and J2b for J2. Thus,
we determined the distribution of these clades in both
patients and controls (table 4). In the case of the 14484/
ND6 mutation, the J1 subclades were represented, at
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Table 3
Probability of Association between Haplogroups
J1 and J2 and Primary LHON Mutations
HAPLOGROUP
PROBABILITY (P) OF ASSOCIATION
WITH LHON MUTATION
11778 3460 14484
J1 .003 .638 !.001
J2 .006 1.000 1.000
NOTE.—P values were obtained using Fisher’s ex-
act test (two-tailed). The frequencies of haplogroups
J1 and J2 for subjects with LHON (subdivided ac-
cording to LHON mutation) were compared with
those of haplogroups J1 and J2 of Italian controls.
In the comparisons, all non–J haplogroups were
pooled together.
Table 4
Frequencies of the J Subclades in Italian Patients with LHON and Control Individuals
J SUBCLADES
NO. (%) OF PATIENTS WITH LHON WITH MUTATION
NO. (%)
OF CONTROL
INDIVIDUALS
( )np 2,071
11778
( )np 55
3460
( )np 12
14484
( )np 6
14482A
( )np 1
Total
( )np 74
J1:
J1b 1 (1.8) … 1 (16.7) … 2 (2.7) 24 (1.2)
J1c 7 (12.7) … 2 (33.3) 1 (100.0) 10 (13.5) 92 (4.4)
J1d 1 (1.8) … 1 (16.7) … 2 (2.7) 3 (.1)
J2:
J2a 1 (1.8) … … … 1 (1.4) 11 (.5)
J2b 3 (5.5) … … … 3 (4.1) 18 (.9)
most, by two subjects, thus too few to evaluate a possible
accumulation on a speciﬁc J1 subset. In contrast, the dis-
tribution of the 11778/ND4 mutation provides some new
interesting clues. The excess of this mutation in J1 and
J2 appears to be caused exclusively by an excess of J1c
and J2b (Fisher’s and , respectively).Pp .012 Pp .016
Reconnection of Nuclear LHON-Affected Families
into Extended Pedigrees
Once it was determined that the association between
haplogroup J and the 11778/ND4 and 14484/ND6 mu-
tations in the Italian population with LHON is not even
partially due to a founder event but is due to an effect of
the mtDNA background, we focused on the seven double-
and three triple-haplotype identities found among thepro-
bands (table 1), in an effort to reconstruct their maternal
relationships. On the basis of the genealogical reinves-
tigation of these families, two double haplotype iden-
tities (LB79/LB80 and LB02/LB76) (table 1) were im-
mediately discarded because the index cases were indeed
members of the same family but had received indepen-
dent diagnoses in different centers. In the remaining eight
cases of haplotype identities, by searching city-council
and church records of birth certiﬁcates, we were able to
formally reconnect six pedigrees into three pairs: BL04
and LB68 (ﬁg. 1A), LB105 and BL02 (ﬁg. 1B), and LB10
and the Brazilian BSL07 (ﬁg. 2). Interestingly, the pair
BL04 and LB68 is reconnected into a pedigree in which
the 3460/ND1mutation is still heteroplasmic in both fam-
ily branches (ﬁg. 1A). For the remaining haplotype iden-
tities, we could not formally certify that they belonged
to the same maternal lineage. However, in all cases, the
close geographical origin of the families strongly sug-
gests a shared female ancestry.
Complete Sequencing of mtDNA Samples
from Reconnected Pedigrees
To further evaluate the molecular identity of the three
reconnected pairs, the six mtDNA samples were com-
pletely sequenced with some control samples. The phy-
logenetic tree in ﬁgure 3 illustrates the mutations relative
to the revised Cambridge reference sequence (rCRS) (An-
drews et al. 1999) and their haplogroup afﬁliations. The
BL04 and LB68 mtDNA samples were identical and were
found to harbor the mutations 3936/ND1 and 14552/
ND6, which are typical of subhaplogroup H12 (Achilli
et al. 2004). Also, the LB105 and BL02 mtDNA samples
were identical and belong to subhaplogroup J1c (Pal-
anichamy et al. 2004). In contrast, the mtDNA of Ital-
ian proband LB10 and Brazilian proband BSL07 were
members of the same subset of J1, newly deﬁned here
as “J1d,” but they were not identical. Relative to the
rCRS, BSL07 harbored the two control-region transi-
tions 16092C and 16129A, both in the heteroplasmic
state, whereas, in LB10, 16092C was homoplasmic and
16129A was absent. This indicates that the most recent
common female ancestor of the extended Italian/Brazil-
ian pedigree (I-1 in ﬁg. 2) harbored 16092C in either
the homoplasmic or heteroplasmic state, whereas the
16129A mutation might have occurred later in the Bra-
zilian branch. To further investigate the status at these
two positions, we sequenced the mtDNA control region
in 12 maternal relatives from the SOA-BR family (4 from
generation III and 8 from generations V and VI, all be-
longing to distant branches of the genealogy) and in 5
www.ajhg.org The American Journal of Human Genetics Volume 78 April 2006 569
Figure 1 Two of the extended pedigrees, after the reconnection
of apparently unrelated familial groups. A, The relationship between
the BL04 (Carelli et al. 1997; Lodi et al. 2002) and LB68 pedigrees.
These pedigrees are from the same Italian region (Emilia). Both pro-
bands, indicated by the dotted arrows, suffered typical LHON, with
severe visual loss in their twenties; their mtDNAs were homoplasmic
for the 3460/ND1 mutation on an identical H haplotype (table 1). An
excess of affected females (4:2) is apparent, and all available affected
subjects (4 of 6) harbored only homoplasmic mutant mtDNA. In con-
trast, the survey of available unaffected maternally related individuals
showed that the 3460 mutation was heteroplasmic in multiple subjects
from both families. Arrows indicate the subjects available for DNA
testing of the 3460 mutation; an asterisk (*) indicates heteroplasmy,
whereas the absence of the asterisk indicates homoplasmy. The results
of the DNA testing suggest that the risk of developing LHON increases
consistently only when the mutant mtDNA shifts to homoplasmy and
partially explains the unusual prevalence of affected females in the
BL04/LB68 extended family. B, The reconstructed 6-generation ped-
igree generated from the families LB105 (Vergani et al. 1995; Carelli
et al. 1997; Lodi et al. 2000) and BL02, both also originating from
the same geographical area (Abruzzo). All available subjects along the
maternal line in both families were homoplasmic for the 11778/ND4
mutation. The male:female ratio (9:3) in the extended family matches
the reported values for the 11778/ND4 mutation (Carelli et al. 2004).
available maternal relatives of the Italian branch (table
5). All other control-region positions were found to be
invariant, but the differences at np 16092 and np 16129
were conﬁrmed. All individuals from the Italian branch
were homoplasmic for 16092C and lacked the mutation
16129A, as was already seen in proband LB10. In con-
trast, the investigation of the 12 maternal relatives from
SOA-BR, including the proband BSL07, revealed, as in-
dicated by the RFLP quantiﬁcation, a wide variability
in the degree of heteroplasmy at both positions in all
subjects except one (V-132), who lacked 16129A.
Discussion
The Role of mtDNA Backgrounds in LHON Expression
Our survey of a very large number of independent
LHON mutational events in Italian index cases con-
ﬁrms that the 11778/ND4 and 14484/ND6 mutations
are preferentially associated with haplogroup J, whereas
the 3460 mutation is distributed randomly among all
mtDNA haplogroups. Is this new? The answer is no.
This has been known for several years. However, what
is new is that now we know that association studies
of haplogroups, such as J, that are ancient and deeply
rooted in the world mtDNAphylogeny, might easilymiss
signiﬁcant differences between patients and controls be-
cause of the presence of multiple subclades, with differ-
ent geographical and ethnical distributions, of which
perhaps only one or a few play a role in disease expres-
sion. In the present study, we addressed this issue. We
ﬁrst performed the analysis at the level of subhaplo-
groups J1 and J2, observing a signiﬁcant association be-
tween the 11778/ND4 mutation and both haplogroups
J1 and J2 and between the 14484/ND6 mutation and
haplogroup J1. Then, we tried to determine whether the
haplogroup association could be narrowed further at
the subclade level. We deﬁned a novel subclade of J,
which we named “J1d”; thus, all J mtDNA now falls
into known subclades: J1b, J1c, and J1d for J1 and J2a
and J2b for J2. Unfortunately, when subclades are an-
alyzed, the problem of sufﬁcient sample sizes becomes
increasingly acute, even for analysis of a relatively large
number of patients. In the case of the 14484/ND6 mu-
tation, the J1 subclades encompassed too few subjects
to evaluate a possible accumulation on a speciﬁc J1 sub-
set. However, the distribution of the much more com-
mon 11778/ND4 mutation revealed that the excess of
this mutation in J1 mtDNA and J2 mtDNA is due ex-
clusively to an excess of J1c and J2b, respectively.
What is peculiar at the level of the mtDNA sequence
in J1c and J2b? To answer this question, we evaluated
the complete mtDNA sequences of the different J sub-
clades. In addition to the nonsynonymousNDmutations
at np 4216, np 10398, and np 13708, all J mtDNAs are
characterized by a CrA transversion at np 15452 (ﬁg.
3) that changes a nonconserved leucine to an isoleucine
at position 236 of cytochrome b (cyt b)—the only mi-
tochondrial subunit of complex III. Furthermore, J1c
mtDNA harbors a second change in cyt b: a TrC tran-
sition at np 14798 that causes the substitution of a non-
conserved phenylalanine with a leucine at position 19.
J1b and J1d lack additional amino acid changes in cyt
b. J2 also carries a second amino acid change in cyt b—
a highly conserved aspartic acid to an asparagine at
position 171—that is due to the GrA transition at np
15257. However, only J2b is additionally characterized
by a third change in cyt b—a valine-to-methionine
change at position 356—that is due to the GrA tran-
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Figure 2 The reconstructed pedigree generated from families BSL07 and LB10. The BSL07 family originates from the state of Espirito
Santo in Brazil and is a nuclear subset of the large Brazilian SOA-BR pedigree, which has been completely reconstructed and investigated from
a genetic, epidemiological, and clinical point of view (Sadun et al. 2003, 2004; Salomao et al. 2004). Brieﬂy, the SOA-BR family numbers ∼360
family members, 128 of whom are maternally related. Of the latter, 35 are affected (23 are alive, 2 of whom are recent cases and became
affected in the past 2 years). All 122 individuals investigated are homoplasmic for the 11778/ND4 mutation. The woman—daughter of the
most recent common female ancestor of the entire pedigree, who migrated to Brazil and gave rise to the Brazilian branch—was born in 1861
in the Veneto region of northern Italy, the same geographical area from which the LB10 family originates.
sition at np 15812. In brief, J1c, the subclade preferen-
tially associated with the 11778/ND4 mutation and the
most common of the J1 subclades in Italy (∼77% of J1
mtDNA), is characterized by two amino acid changes
(L236I-F19L) in cyt b. J2b, the other subclade of J for
which there is an excess of patients with the 11778/ND4
mutation, harbors three amino acid changes (L236I-
D171N-V356M) in cyt b. Could this accumulation of cyt
b amino acid changes be due to chance? Obviously, we
cannot exclude the possibility. However, those nucleotide
positions are very stable, with only a single recurrence (in
haplogroup K) reported for the TrC transition at np
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Figure 3 Tree encompassing the complete mtDNA sequences
(GenBank) observed in the three pairs of reconnected LHON-affected
families—BL04 and LB68 (haplogroup H12), LB105 and BL02 (hap-
logroup J1c), BSL07 and LB10 (haplogroup J1d)—together with those
of mtDNAs that are representative of all other subclades of J. Se-
quences 2 (J2a) and 3 (J2b) are new and from Italian control individ-
uals, whereas sequence 1 (J1b) corresponds to B30 (Palanichamy et
al. 2004). The tree is rooted using the reference sequence rCRS (An-
drews et al. 1999)—a member of haplogroup H2b—as an outgroup.
Mutations are shown on the branches; they are transitions unless the
base change is explicitly indicated. Insertions are sufﬁxed with a plus
sign () and the inserted nucleotide, and deletions have a “d” preﬁx.
Heteroplasmic positions (boxed) in BSL07 are indicated by an “h”
following the nucleotide position. In LB10, 16092C was homoplasmic
and 16129A was absent. Underlining indicates recurrent mutations;
“s” indicates synonymous mutations, whereas “ns” indicates nonsyn-
onymous mutations. The arrows indicate the nonsynonymous J poly-
morphisms that might have a role in modulation of LHON expression.
LHON mutations are shown in italics and were added to the tree after
phylogeny construction.
Table 5
Control-Region Variation of mtDNAs
from the Extended Italian/Brazilian Pedigree
The table is available in its entirety in the online
edition of The American Journal of Human Genetics.
14798 (Kivisild et al. 2005). Furthermore, the recent ﬁnd-
ing of a stable mitochondrial supercomplex that consists
of complex I and dimeric complex III (Acin-Perez et al.
2004; Dudkina et al. 2005) raises the possibility that
amino acid changes in the two complexes might directly
interact with each other and inﬂuence the functional
effect of the 11778/ND4 mutation and possibly also that
of the 14484/ND6 mutation.
Finally, the observation that the excess of haplogroup
J in patients with the 11778/ND4 mutation in Italy, and
most likely in western Europe, might be largely attrib-
uted to J1c also explains the lack of association of LHON
with haplogroup J in Iran (Houshmand et al. 2004),
despite the fact that the frequency of J in that region is
similar to that reported for European populations. The
study by Quintana-Murci et al. (2004) reports a J fre-
quency of ∼8% in western Asia (48 J1 and 8 J2 mtDNAs
in 702 subjects), but the control-region motifs of these
mtDNAs reveal that the Asian J1 mtDNAs belong mainly
to J1b (37 of 48; 77.0%), a result in sharp contrast to
the frequency of the J1 subclades in Italy (and Europe),
where J1b is much less common (24 of 119; 20.2%) and
J1c is, by far, the most represented. Thus, the Iranian
data can be easily explained, since the J subclades are
differently distributed in western Eurasia, and represent
a paradigmatic example of the need to improve the level
of resolution of mtDNA haplogroups used in association
studies.
Heteroplasmy at Two Nucleotide Positions
in the Extended Italian/Brazilian Pedigree
The ﬁnding that all individuals from the Italian LB10
family were homoplasmic for 16092C and lacked the
mutation 16129A but that their 12 maternal relatives
from the Brazilian branch harbored a wide variability
in the degree of heteroplasmy at both positions implies
that 16092C was already present, in either the homo-
plasmic or heteroplasmic state, in the most recent female
ancestor of the Italian and Brazilian branches. In the
ﬁrst scenario, this site mutated to a T in one of her very
early Brazilian descendants (her daughter or granddaugh-
ter) and remained heteroplasmic in the SOA-BR pedi-
gree. Alternatively, 16092 was already heteroplasmic in
subject I-1 (ﬁg. 2) and was ﬁxed as a C in the Italian
branch only. Nucleotide position 16129 could also have
been heteroplasmic in I-1 and lost the 16129A form only
in the Italian branch. However, this mutation also might
have occurred more recently in one of her very early
Brazilian descendants. Note that neither 16092C nor
16129A has been observed in any of the 119 mtDNAs
belonging to the J1 haplogroup present in the 2,071
Italian controls. In any case, all but one of the Brazilian
subjects harbor both 16092 and 16129 in the hetero-
plasmic state, which suggests that such a condition is
generalized to the entire extended SOA-BR family. The
presence of two alternative forms at two nucleotide po-
sitions raises the question of the numbers of different
mtDNA molecules coexisting in the Brazilian subjects.
The heteroplasmy quantiﬁcation reported in table 5 pro-
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vides some clues on this issue. We noted that the amount
of heteroplasmy is very different in the family members,
without any constant ratio (a constant ratio would be
suggestive of an association in cis between 16092C and
16129A), and that the sum of the percentages of 16092C
and 16129A sometimes reaches almost 100%, although
it is generally much less than that. Overall, this indicates
that there is a condition of triplasmy with a population
of rCRS-like mtDNAs (16092T-16129G) that do not
harbor either 16092C or 16129A and two trans popu-
lations, one with only 16092C (16092C-16129G) and
the other with only 16129A (16092T-16129A), in most
of the Brazilian subjects. Most importantly, there is no
evidence of a fourth mtDNA species (tetraplasmy) in
which 16092C and 16129A are in cis on the same mol-
ecule. The existence of such a species will become evident
by detection of at least one subject in whom the sum of
the percentages of 16092C and 16129A is 1100%. Ob-
viously, such a species is expected only if there is recom-
bination between mtDNA molecules (D’Aurelio et al.
2004; Kraytsberg et al. 2004; Zsurka et al. 2005), in
particular between the trans species 16092C-16129G
and 16092T-16129A. Our survey did not detect such a
subject in the SOA-BR pedigree and thus does not sup-
port, at least for the moment, the existence of in vivo
mtDNA recombination. Obviously, we cannot rule out
the possibility either, especially taking into account that
16092 and 16129 are only 37 nps apart (Zsurka et al.
2005); thus, they are not very likely to be involved in a
recombination event, even if recombination could occur.
In any case, the SOA-BR extended pedigree is an ideal
candidate for in-depth investigation of not only the issue
of mtDNA recombination but also its potential role in
generating mtDNA-sequence variation that might be
transmissible in the germline through the generations.
In conclusion, this study reveals that the largemajority
of the LHON mutations in affected Italian families are
due to independent mutational events, thus conﬁrming
that the preferential association of the LHONmutations
11778/ND4 with haplogroups J1 and J2 and 14484/
ND6 with haplogroup J1 is attributable not to founder
events but to a true mtDNA background effect. In the
case of the 11778/ND4 mutation, such a role of the
mtDNA background was narrowed to the subclades J1c
and J2b, which both, intriguingly, harbor unique com-
binations of amino acid changes in cyt b. This ﬁnding
raises the possibility that the LHON 11778/ND4 mu-
tation, when occurring on either a J1c or J2b mtDNA,
increases the risk of disease expression because it more
easily affects some functional parameter of the mitochon-
drial supercomplex formed by respiratory-chain com-
plexes I and III. Finally, we also identiﬁed eight haplo-
type identities that were suggestive of founder events.
The combined use of haplotype data, city-council and
church birth-certiﬁcate records, and the sequencing of
entire mtDNAs allowed the reconnection into extended
pedigrees of families that were not known to be related,
the extended Italian/Brazilian SOA-BR family being the
most remarkable example. Studies of these large pedi-
grees offer multiple and powerful opportunities for in-
vestigation, including the possibility of detecting in vivo
mtDNA recombination, if this indeed occurs.
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